ACETAZOLAMIDE
Marketedupdated 2mo agoby Eywa Pharma Inc
Approvedcommunity read0 votes
indications
investigational
Epilepsy
all catalysts(24)
approval · 23
Oct 27, 2016
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Nov 20, 2017
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Oct 17, 2019
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Oct 7, 2020
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Jul 26, 2022
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Feb 9, 2023
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Apr 4, 2023
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
May 24, 2023
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Aug 9, 2023
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Sep 11, 2023
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
May 15, 2024
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Mar 12, 2025
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Mar 13, 2025
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
May 30, 2025
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Sep 16, 2025
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Sep 16, 2025
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
phase 3 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that